Masimo Corporation (MASI)

Market Cap	6.03B
Revenue (ttm)	1.98B
Net Income (ttm)	79.10M
Shares Out	53.18M
EPS (ttm)	1.47
PE Ratio	77.16
Forward PE	30.95
Dividend	n/a
Ex-Dividend Date	n/a

Volume	805,836
Open	117.37
Previous Close	116.40
Day's Range	112.07 - 117.37
52-Week Range	75.22 - 162.00
Beta	1.00
Analysts	Buy
Price Target	155.40 (+37.01%)
Earnings Date	Aug 6, 2024

About MASI

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 8, 2007
• Employees: 3,800
• Stock Exchange: NASDAQ
• Ticker Symbol: MASI

Financial Performance

In 2023, Masimo's revenue was $2.05 billion, an increase of 0.60% compared to the previous year's $2.04 billion. Earnings were $81.50 million, a decrease of -43.21%.

Analyst Forecast

According to 7 analysts, the average rating for MASI stock is "Buy." The 12-month stock price forecast is $155.4, which is an increase of 37.01% from the latest price.

Price Target

$155.4

(37.01% upside)

Analyst Consensus: Buy